HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hervé Tilly Selected Research
Hervé Tilly Research Topics
Disease
45
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023 - 01/2002
35
Lymphoma (Lymphomas)
02/2024 - 05/2002
30
Neoplasms (Cancer)
12/2023 - 02/2004
26
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
02/2024 - 07/2008
23
B-Cell Lymphoma (Lymphoma, B Cell)
12/2023 - 06/2005
13
Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2022 - 12/2003
8
Hodgkin Disease (Hodgkin's Disease)
01/2022 - 12/2007
7
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2023 - 01/2014
6
Infections
07/2022 - 05/2015
6
Disease Progression
01/2021 - 07/2008
6
Neutropenia
01/2018 - 11/2005
5
Residual Neoplasm
11/2023 - 01/2016
5
T-Cell Lymphoma (Lymphoma, T Cell)
01/2022 - 09/2010
5
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2018 - 09/2010
3
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2017 - 09/2010
2
Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
02/2024 - 06/2017
2
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2022 - 04/2018
2
Fatigue
01/2020 - 01/2019
2
Fever (Fevers)
08/2018 - 06/2005
2
Febrile Neutropenia
01/2018 - 05/2015
2
Sarcopenia
07/2014 - 04/2014
2
Hematologic Neoplasms (Hematological Malignancy)
11/2013 - 01/2005
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2013 - 08/2011
1
Inflammation (Inflammations)
07/2023
1
Myocardial Ischemia (Ischemic Heart Diseases)
12/2022
1
Heart Valve Diseases (Valvular Heart Disease)
12/2022
1
Venous Thrombosis (Deep-Vein Thrombosis)
07/2022
Drug/Important Bio-Agent (IBA)
56
Rituximab (Mabthera)
FDA Link
02/2024 - 01/2002
19
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2023 - 01/2002
19
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2023 - 01/2002
17
Prednisone (Sone)
FDA Link
Generic
01/2023 - 01/2002
17
Vincristine (Oncovin)
FDA Link
Generic
01/2023 - 01/2002
10
Lenalidomide (CC 5013)
FDA Link
10/2022 - 08/2017
8
obinutuzumab
IBA
01/2022 - 05/2012
8
DNA (Deoxyribonucleic Acid)
IBA
10/2020 - 10/2012
6
polatuzumab vedotin
IBA
01/2023 - 01/2019
6
Biomarkers (Surrogate Marker)
IBA
12/2022 - 01/2016
6
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
01/2021 - 01/2012
6
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2021 - 09/2010
5
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2022 - 11/2013
5
Cell-Free Nucleic Acids
IBA
10/2020 - 07/2015
5
Monoclonal Antibodies
IBA
08/2013 - 01/2002
4
Etoposide (VP 16)
FDA Link
Generic
11/2015 - 09/2010
3
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
12/2023 - 06/2005
3
Anthracyclines
IBA
12/2022 - 01/2012
3
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
12/2022 - 09/2013
3
Gemcitabine
FDA Link
01/2022 - 11/2013
3
Bendamustine Hydrochloride
FDA Link
01/2021 - 12/2016
3
Immunoconjugates (Immunoconjugate)
IBA
01/2021 - 01/2016
3
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
01/2020 - 04/2015
3
Melphalan (Alkeran)
FDA Link
Generic
11/2015 - 04/2011
3
Bleomycin (Blenoxane)
FDA Link
Generic
07/2015 - 03/2005
2
Chlorambucil (Leukeran)
FDA Link
02/2024 - 06/2017
2
Enhancer of Zeste Homolog 2 Protein
IBA
11/2022 - 06/2015
2
Circulating Tumor DNA
IBA
01/2022 - 01/2021
2
Indicators and Reagents (Reagents)
IBA
01/2021 - 11/2017
2
Cisplatin (Platino)
FDA Link
Generic
01/2021 - 11/2020
2
Carboplatin (JM8)
FDA Link
Generic
01/2021 - 11/2020
2
tazemetostat
IBA
11/2020 - 01/2020
2
Dexamethasone (Maxidex)
FDA Link
Generic
11/2020 - 02/2011
2
Antigens
IBA
01/2017 - 01/2002
2
Brentuximab Vedotin
IBA
01/2017 - 03/2016
2
Histone Deacetylase Inhibitors
IBA
01/2016 - 04/2015
2
Exportin 1 Protein
IBA
01/2016 - 01/2016
2
Carmustine (FIVB)
FDA Link
11/2015 - 12/2014
2
Vindesine (Vindesin)
IBA
12/2014 - 03/2005
2
Yttrium-90
IBA
12/2014 - 04/2011
2
ibritumomab tiuxetan (Zevalin)
FDA Link
12/2014 - 04/2011
2
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
05/2013 - 11/2005
2
Interferons
IBA
08/2011 - 07/2008
2
Methotrexate (Mexate)
FDA Link
Generic
02/2011 - 09/2010
1
Immunoglobulins (Immunoglobulin)
IBA
02/2024
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
02/2024
1
RNA (Ribonucleic Acid)
IBA
02/2024
1
Prealbumin (Transthyretin)
IBA
07/2023
1
Sodium-Potassium-Chloride Symporters
IBA
01/2023
1
Complementary DNA (cDNA)
IBA
12/2022
1
Agammaglobulinaemia Tyrosine Kinase
IBA
03/2022
1
ibrutinib
IBA
03/2022
1
Salts
IBA
03/2022
1
Platinum
IBA
03/2022
1
Nivolumab
IBA
01/2022
1
Arginine (L-Arginine)
FDA Link
04/2021
1
Glycine (Aminoacetic Acid)
FDA Link
Generic
04/2021
1
Fluorine
IBA
04/2021
Therapy/Procedure
37
Drug Therapy (Chemotherapy)
12/2023 - 01/2002
35
Therapeutics
10/2022 - 05/2002
15
Stem Cell Transplantation
03/2022 - 05/2002
4
Transplantation
11/2020 - 05/2007
4
Induction Chemotherapy
11/2020 - 12/2003
3
Ligation
01/2020 - 04/2015
3
Salvage Therapy
01/2016 - 07/2008
3
BEAM regimen
11/2015 - 04/2011
2
Autologous Transplantation
01/2021 - 08/2011
2
Combination Drug Therapy (Combination Chemotherapy)
01/2021 - 01/2017
2
VAP-cyclo protocol
05/2013 - 01/2002
2
Radiotherapy
03/2007 - 03/2005
2
Chemoradiotherapy
03/2007 - 03/2005
1
Vascular Access Devices (Arterial Line)
07/2022
1
Catheters
07/2022